|
⚲
|
| Keyboard |
| Huckel Hubert E MD
✚
|
|
|---|---|
| CIK # | 0001121608 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001121608] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Catalyst Pharmaceuticals Inc | |
| Huckel Hubert E MD | |
| Titan Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2014-10-02 | Tax withheld | 9,964 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2014-10-02 | Option exercise | 30,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2014-10-02 | Option exercise | 30,000 | $0.90 | 27,000 |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2014-08-28 | Grant | 25,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2014-08-28 | Grant | 25,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2012-12-12 | Grant | 50,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2012-05-24 | Buy | 125,000 | $0.80 | 100,000 |
|
Catalyst Pharmaceuticals Inc CPRX
Warrants to purchase common stock · derivative
|
2012-05-24 | Buy | 125,000 | ||
|
Titan Pharmaceuticals Inc TTNP.OB
Option to Purchase Common Stock · derivative
|
2012-01-03 | Grant | 35,000 | $0.00 |